| | | | | | | | | | | | | | | | |
| |
| Issue Date FY: 2025 ( Subtotal = $765,229 ) |
| 2025 | 2025 | CREIGHTON UNIVERSITY | 2500 CALIFORNIA PLAZA | OMAHA | NE | 68178-0133 | DOUGLAS | USA | R01MH133600 | Epigenetic regulation of the neuroendocrine axis in brain development and behavior | 000 | 1 | NIH | 11/13/2024 | $439,804 |
| 2025 | 2025 | CREIGHTON UNIVERSITY | 2500 CALIFORNIA PLAZA | OMAHA | NE | 68178-0133 | DOUGLAS | USA | R21AI180688 | Heteromers and L-type calcium channels: Increasing the potency of emodepside in filarial nematode model, Brugia malayi | 000 | 1 | NIH | 11/15/2024 | $226,738 |
| 2025 | 2024 | CREIGHTON UNIVERSITY | 2500 CALIFORNIA PLAZA | OMAHA | NE | 68178-0133 | DOUGLAS | USA | K01DC018852 | Development of Afferent and Efferent Innervation in the Inner Ear | 001 | 6 | NIH | 10/16/2024 | $115,601 |
| 2025 | 2023 | CREIGHTON UNIVERSITY | 2500 CALIFORNIA PLAZA | OMAHA | NE | 68178-0133 | DOUGLAS | USA | R01DC016680 | Clinical factors in aminoglycoside-induced ototoxicity | 000 | 5 | NIH | 10/16/2024 | $0 |
| 2025 | 2022 | CREIGHTON UNIVERSITY | 2500 CALIFORNIA PLAZA | OMAHA | NE | 68178-0133 | DOUGLAS | USA | R01NS103763 | Mechanisms of prion strain dynamics | 000 | 5 | NIH | 11/12/2024 | -$16,914 |
|
| Issue Date FY: 2024 ( Subtotal = $8,329,441 ) (Continued on the next page) |
| 2024 | 2024 | CREIGHTON UNIVERSITY | 2500 CALIFORNIA PLAZA | OMAHA | NE | 68178-0133 | DOUGLAS | USA | R00DC020759 | Subthreshold vestibular stimulation as a strategy for rehabilitation | 000 | 2 | NIH | 1/29/2024 | $248,711 |
| 2024 | 2024 | CREIGHTON UNIVERSITY | 2500 CALIFORNIA PLAZA | OMAHA | NE | 68178-0133 | DOUGLAS | USA | R21DC020773 | Dissecting the sensory hair cell nucleus: Development of a novel method for investigating chromatin interactions (Tn5-Capture) in small cell numbers | 001 | 2 | NIH | 5/2/2024 | $18,187 |
| 2024 | 2024 | CREIGHTON UNIVERSITY | 2500 CALIFORNIA PLAZA | OMAHA | NE | 68178-0133 | DOUGLAS | USA | R01NS134993 | A Novel Therapeutic Strategy Targeting Neuroinflammation for Global Cerebral Ischemia Associated with Cardiac Arrest | 000 | 1 | NIH | 8/6/2024 | $426,656 |
| 2024 | 2024 | CREIGHTON UNIVERSITY | 2500 CALIFORNIA PLAZA | OMAHA | NE | 68178-0133 | DOUGLAS | USA | NU58DP007612 | Center for Promoting Health and Health Equity-Racial and Ethnic Approaches to Community Health 2 (CPHHE-REACH 2) | 00 | 2 | CDC | 9/9/2024 | $222,222 |
| 2024 | 2024 | CREIGHTON UNIVERSITY | 2500 CALIFORNIA PLAZA | OMAHA | NE | 68178-0133 | DOUGLAS | USA | NU58DP007612 | Center for Promoting Health and Health Equity-Racial and Ethnic Approaches to Community Health 2 (CPHHE-REACH 2) | 00 | 2 | CDC | 9/9/2024 | $680,038 |
| 2024 | 2024 | CREIGHTON UNIVERSITY | 2500 CALIFORNIA PLAZA | OMAHA | NE | 68178-0133 | DOUGLAS | USA | NU58DP007612 | Center for Promoting Health and Health Equity-Racial and Ethnic Approaches to Community Health 2 (CPHHE-REACH 2) | 01 | 2 | CDC | 9/18/2024 | $0 |
| 2024 | 2024 | CREIGHTON UNIVERSITY | 2500 CALIFORNIA PLAZA | OMAHA | NE | 68178-0133 | DOUGLAS | USA | NU58DP007612 | Center for Promoting Health and Health Equity-Racial and Ethnic Approaches to Community Health 2 (CPHHE-REACH 2) | 01 | 2 | CDC | 9/18/2024 | $0 |
| 2024 | 2024 | CREIGHTON UNIVERSITY | 2500 CALIFORNIA PLAZA | OMAHA | NE | 68178-0133 | DOUGLAS | USA | R01NS126418 | Autoresuscitation and SUDEP | 001 | 3 | NIH | 5/6/2024 | $25,106 |
| 2024 | 2024 | CREIGHTON UNIVERSITY | 2500 CALIFORNIA PLAZA | OMAHA | NE | 68178-0133 | DOUGLAS | USA | R01AI167880 | Redox Regulation of DksA-dependent Borrelia burgdorferi infectivity | 000 | 2 | NIH | 7/18/2024 | $350,000 |
| 2024 | 2024 | CREIGHTON UNIVERSITY | 2500 CALIFORNIA PLAZA | OMAHA | NE | 68178-0133 | DOUGLAS | USA | R01AI167880 | Redox Regulation of DksA-dependent Borrelia burgdorferi infectivity | 000 | 2 | NIH | 7/18/2024 | $72,997 |
| 2024 | 2024 | CREIGHTON UNIVERSITY | 2500 CALIFORNIA PLAZA | OMAHA | NE | 68178-0133 | DOUGLAS | USA | R01NS126418 | Autoresuscitation and SUDEP | 000 | 3 | NIH | 1/10/2024 | $322,790 |
| 2024 | 2024 | CREIGHTON UNIVERSITY | 2500 CALIFORNIA PLAZA | OMAHA | NE | 68178-0133 | DOUGLAS | USA | R01CA253573 | Targeting aberrant anti-apoptotic signaling for prevention of skin cancer | 000 | 5 | NIH | 4/9/2024 | $316,190 |
| 2024 | 2024 | CREIGHTON UNIVERSITY | 2500 CALIFORNIA PLAZA | OMAHA | NE | 68178-0133 | DOUGLAS | USA | R21AI173819 | Cholinergic anthelmintics: Tachyphylaxis mechanisms and control in a parasitic nematode model,Brugia malayi | 002 | 3 | NIH | 5/21/2024 | $223,622 |
| 2024 | 2024 | CREIGHTON UNIVERSITY | 2500 CALIFORNIA PLAZA | OMAHA | NE | 68178-0133 | DOUGLAS | USA | R21AI185362 | Role of a RAG1-DCAF1(VprBP)-Ezh2 axis in B cell development | 001 | 1 | NIH | 9/12/2024 | $22,050 |
| 2024 | 2024 | CREIGHTON UNIVERSITY | 2500 CALIFORNIA PLAZA | OMAHA | NE | 68178-0133 | DOUGLAS | USA | R01DK122558 | Skeletal Effects of Type 1 Diabetes | 000 | 5 | NIH | 8/15/2024 | $341,725 |
| 2024 | 2024 | CREIGHTON UNIVERSITY | 2500 CALIFORNIA PLAZA | OMAHA | NE | 68178-0133 | DOUGLAS | USA | R15DA058811 | The Developmental Effects of Environmental Enrichment on the Minor Cannabinoid Drug Reward and Cannabinoid Receptor Levels | 000 | 1 | NIH | 8/1/2024 | $90,924 |
| 2024 | 2024 | CREIGHTON UNIVERSITY | 2500 CALIFORNIA PLAZA | OMAHA | NE | 68178-0133 | DOUGLAS | USA | R15DA058811 | The Developmental Effects of Environmental Enrichment on the Minor Cannabinoid Drug Reward and Cannabinoid Receptor Levels | 000 | 1 | NIH | 8/1/2024 | $350,000 |
| 2024 | 2024 | CREIGHTON UNIVERSITY | 2500 CALIFORNIA PLAZA | OMAHA | NE | 68178-0133 | DOUGLAS | USA | R01DC018850 | Repurposing an FDA approved Drug, B-Raf Kinase Inhibitor Dabrafenib for Protection from Cisplatin- and Noise- induced Hearing Loss | 002 | 4 | NIH | 8/22/2024 | -$402,856 |
| 2024 | 2024 | CREIGHTON UNIVERSITY | 2500 CALIFORNIA PLAZA | OMAHA | NE | 68178-0133 | DOUGLAS | USA | R01NS133050 | Contributions of prion strains and substrains to prion zoonotic potential and evolution | 000 | 2 | NIH | 6/14/2024 | $527,952 |
| 2024 | 2024 | CREIGHTON UNIVERSITY | 2500 CALIFORNIA PLAZA | OMAHA | NE | 68178-0133 | DOUGLAS | USA | R00ES033259 | The Role of Aquaporin 3 in Arsenic-Induced DNA Damage and Mutagenesis | 000 | 4 | NIH | 7/31/2024 | $236,245 |
| 2024 | 2024 | CREIGHTON UNIVERSITY | 2500 CALIFORNIA PLAZA | OMAHA | NE | 68178-0133 | DOUGLAS | USA | R01HL164593 | A Novel Approach to Target Neutrophilic Airway Inflammation and Airway Hyperresponsiveness in Therapy-Resistant (Refractory) Asthma. | 000 | 2 | NIH | 6/17/2024 | $79,893 |
| 2024 | 2024 | CREIGHTON UNIVERSITY | 2500 CALIFORNIA PLAZA | OMAHA | NE | 68178-0133 | DOUGLAS | USA | R01HL164593 | A Novel Approach to Target Neutrophilic Airway Inflammation and Airway Hyperresponsiveness in Therapy-Resistant (Refractory) Asthma. | 000 | 2 | NIH | 6/17/2024 | $343,000 |
| 2024 | 2024 | CREIGHTON UNIVERSITY | 2500 CALIFORNIA PLAZA | OMAHA | NE | 68178-0133 | DOUGLAS | USA | R25DC021132 | Enhancing Diverse Graduate Student Opportunities in Auditory and Vestibular Neuroscience | 000 | 1 | NIH | 7/8/2024 | $99,658 |
| 2024 | 2024 | CREIGHTON UNIVERSITY | 2500 CALIFORNIA PLAZA | OMAHA | NE | 68178-0133 | DOUGLAS | USA | R21AI185362 | Role of a RAG1-DCAF1(VprBP)-Ezh2 axis in B cell development | 000 | 1 | NIH | 6/5/2024 | $198,450 |
| 2024 | 2024 | CREIGHTON UNIVERSITY | 2500 CALIFORNIA PLAZA | OMAHA | NE | 68178-0133 | DOUGLAS | USA | R01DC018850 | Repurposing an FDA approved Drug, B-Raf Kinase Inhibitor Dabrafenib for Protection from Cisplatin- and Noise- induced Hearing Loss | 001 | 4 | NIH | 5/3/2024 | $40,286 |
| 2024 | 2024 | CREIGHTON UNIVERSITY | 2500 CALIFORNIA PLAZA | OMAHA | NE | 68178-0133 | DOUGLAS | USA | R21DC020983 | Understanding the role of stress hormones in Meniere's disease | 000 | 1 | NIH | 5/4/2024 | $197,285 |
| 2024 | 2024 | CREIGHTON UNIVERSITY | 2500 CALIFORNIA PLAZA | OMAHA | NE | 68178-0133 | DOUGLAS | USA | R01DC021070 | Identification and characterization of novel functions for the Usher proteins in the inner ear | 000 | 2 | NIH | 5/9/2024 | $491,052 |
| 2024 | 2024 | CREIGHTON UNIVERSITY | 2500 CALIFORNIA PLAZA | OMAHA | NE | 68178-0133 | DOUGLAS | USA | R00DC020759 | Subthreshold vestibular stimulation as a strategy for rehabilitation | 001 | 2 | NIH | 5/13/2024 | $9,243 |
| 2024 | 2024 | CREIGHTON UNIVERSITY | 2500 CALIFORNIA PLAZA | OMAHA | NE | 68178-0133 | DOUGLAS | USA | P20GM139762 | The Translational Hearing Center | 004 | 4 | NIH | 6/11/2024 | $440,259 |
| 2024 | 2024 | CREIGHTON UNIVERSITY | 2500 CALIFORNIA PLAZA | OMAHA | NE | 68178-0133 | DOUGLAS | USA | P20GM139762 | The Translational Hearing Center | 003 | 4 | NIH | 6/10/2024 | $217,509 |
| 2024 | 2024 | CREIGHTON UNIVERSITY | 2500 CALIFORNIA PLAZA | OMAHA | NE | 68178-0133 | DOUGLAS | USA | R21DC020983 | Understanding the role of stress hormones in Meniere's disease | 002 | 1 | NIH | 5/9/2024 | $3,055 |
| 2024 | 2024 | CREIGHTON UNIVERSITY | 2500 CALIFORNIA PLAZA | OMAHA | NE | 68178-0133 | DOUGLAS | USA | R21DC020983 | Understanding the role of stress hormones in Meniere's disease | 001 | 1 | NIH | 5/8/2024 | -$16,590 |
| 2024 | 2024 | CREIGHTON UNIVERSITY | 2500 CALIFORNIA PLAZA | OMAHA | NE | 68178-0133 | DOUGLAS | USA | P20GM139762 | The Translational Hearing Center | 002 | 4 | NIH | 5/31/2024 | $250,000 |
| 2024 | 2024 | CREIGHTON UNIVERSITY | 2500 CALIFORNIA PLAZA | OMAHA | NE | 68178-0133 | DOUGLAS | USA | P20GM139762 | The Translational Hearing Center | 001 | 4 | NIH | 3/27/2024 | $1,957,592 |
| 2024 | 2024 | CREIGHTON UNIVERSITY | 2500 CALIFORNIA PLAZA | OMAHA | NE | 68178-0133 | DOUGLAS | USA | R01AG077574 | Regulatory Mechanisms Governing BubR1 Protein Stability During Stress and Aging | 000 | 3 | NIH | 5/7/2024 | $298,275 |
| 2024 | 2024 | CREIGHTON UNIVERSITY | 2500 CALIFORNIA PLAZA | OMAHA | NE | 68178-0133 | DOUGLAS | USA | R01DC018850 | Repurposing an FDA approved Drug, B-Raf Kinase Inhibitor Dabrafenib for Protection from Cisplatin- and Noise- induced Hearing Loss | 000 | 4 | NIH | 12/12/2023 | $362,571 |
| 2024 | 2024 | CREIGHTON UNIVERSITY | 2500 CALIFORNIA PLAZA | OMAHA | NE | 68178-0133 | DOUGLAS | USA | R21DC020773 | Dissecting the sensory hair cell nucleus: Development of a novel method for investigating chromatin interactions (Tn5-Capture) in small cell numbers | 000 | 2 | NIH | 11/16/2023 | $163,688 |
| 2024 | 2023 | CREIGHTON UNIVERSITY | 2500 CALIFORNIA PLAZA | OMAHA | NE | 68178-0133 | DOUGLAS | USA | NU58DP007612 | Center for Promoting Health and Health Equity-Racial and Ethnic Approaches to Community Health 2 (CPHHE-REACH 2) | 01 | 1 | CDC | 11/30/2023 | $0 |
| 2024 | 2023 | CREIGHTON UNIVERSITY | 2500 CALIFORNIA PLAZA | OMAHA | NE | 68178-0133 | DOUGLAS | USA | NU58DP007612 | Center for Promoting Health and Health Equity-Racial and Ethnic Approaches to Community Health 2 (CPHHE-REACH 2) | 01 | 1 | CDC | 11/30/2023 | $0 |
| 2024 | 2023 | CREIGHTON UNIVERSITY | 2500 CALIFORNIA PLAZA | OMAHA | NE | 68178-0133 | DOUGLAS | USA | F32DC020102 | Repurposing FDA-Approved MEK Inhibitor Trametinib for Protection Against Cisplatin-Induced Hearing Loss | 001 | 2 | NIH | 8/22/2024 | $0 |
| 2024 | 2023 | CREIGHTON UNIVERSITY | 2500 CALIFORNIA PLAZA | OMAHA | NE | 68178-0133 | DOUGLAS | USA | F32DC020102 | Repurposing FDA-Approved MEK Inhibitor Trametinib for Protection Against Cisplatin-Induced Hearing Loss | 000 | 2 | NIH | 1/12/2024 | -$17,135 |
| 2024 | 2023 | CREIGHTON UNIVERSITY | 2500 CALIFORNIA PLAZA | OMAHA | NE | 68178-0133 | DOUGLAS | USA | R21AI173819 | Cholinergic anthelmintics: Tachyphylaxis mechanisms and control in a parasitic nematode model,Brugia malayi | 005 | 2 | NIH | 8/13/2024 | $5,622 |
| 2024 | 2023 | CREIGHTON UNIVERSITY | 2500 CALIFORNIA PLAZA | OMAHA | NE | 68178-0133 | DOUGLAS | USA | R21AI173819 | Cholinergic anthelmintics: Tachyphylaxis mechanisms and control in a parasitic nematode model,Brugia malayi | 001 | 2 | NIH | 3/7/2024 | $186,846 |
|